Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study.
Saved in:
| Title: | Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study. |
|---|---|
| Authors: | Chris Min K; Merck & Co., Inc., Kenilworth, New Jersey, USA., Dockendorf MF; Merck & Co., Inc., Kenilworth, New Jersey, USA., Palcza J; Merck & Co., Inc., Kenilworth, New Jersey, USA., Tseng J; Merck & Co., Inc., Kenilworth, New Jersey, USA., Ma L; Merck & Co., Inc., Kenilworth, New Jersey, USA., Stone JA; Merck & Co., Inc., Kenilworth, New Jersey, USA., Kleijn HJ; Merck & Co., Inc., Kenilworth, New Jersey, USA., Hodsman P; Nucleus Network, Melbourne, Victoria, Australia., Masuo K; Nucleus Network, Melbourne, Victoria, Australia., Tanen M; Merck & Co., Inc., Kenilworth, New Jersey, USA., Troyer MD; Merck & Co., Inc., Kenilworth, New Jersey, USA., van Vugt M; Merck & Co., Inc., Kenilworth, New Jersey, USA., Forman MS; Merck & Co., Inc., Kenilworth, New Jersey, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 May; Vol. 105 (5), pp. 1234-1243. Date of Electronic Publication: 2019 Jan 18. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30347431 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chris+Min+K%22">Chris Min K</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Dockendorf+MF%22">Dockendorf MF</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Palcza+J%22">Palcza J</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Tseng+J%22">Tseng J</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Ma+L%22">Ma L</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Stone+JA%22">Stone JA</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Kleijn+HJ%22">Kleijn HJ</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hodsman+P%22">Hodsman P</searchLink>; Nucleus Network, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Masuo+K%22">Masuo K</searchLink>; Nucleus Network, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Tanen+M%22">Tanen M</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Troyer+MD%22">Troyer MD</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22van+Vugt+M%22">van Vugt M</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Forman+MS%22">Forman MS</searchLink>; Merck & Co., Inc., Kenilworth, New Jersey, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2019 May; Vol. 105 (5), pp. 1234-1243. <i>Date of Electronic Publication: </i>2019 Jan 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30347431 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.1258 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1234 Titles: – TitleFull: Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chris Min K – PersonEntity: Name: NameFull: Dockendorf MF – PersonEntity: Name: NameFull: Palcza J – PersonEntity: Name: NameFull: Tseng J – PersonEntity: Name: NameFull: Ma L – PersonEntity: Name: NameFull: Stone JA – PersonEntity: Name: NameFull: Kleijn HJ – PersonEntity: Name: NameFull: Hodsman P – PersonEntity: Name: NameFull: Masuo K – PersonEntity: Name: NameFull: Tanen M – PersonEntity: Name: NameFull: Troyer MD – PersonEntity: Name: NameFull: van Vugt M – PersonEntity: Name: NameFull: Forman MS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 105 – Type: issue Value: 5 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |